Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback